These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28446795)

  • 21. The genetics of multiple sclerosis: an update 2010.
    Hoffjan S; Akkad DA
    Mol Cell Probes; 2010 Oct; 24(5):237-43. PubMed ID: 20450971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations.
    Weber F; Fontaine B; Cournu-Rebeix I; Kroner A; Knop M; Lutz S; Müller-Sarnowski F; Uhr M; Bettecken T; Kohli M; Ripke S; Ising M; Rieckmann P; Brassat D; Semana G; Babron MC; Mrejen S; Gout C; Lyon-Caen O; Yaouanq J; Edan G; Clanet M; Holsboer F; Clerget-Darpoux F; Müller-Myhsok B
    Genes Immun; 2008 Apr; 9(3):259-63. PubMed ID: 18354419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of IL4 and IL4R polymorphisms with multiple sclerosis susceptibility in Caucasian population: A meta-analysis.
    Zhang Z; Wang L; Sun X; Zhang L; Lu L
    J Neurol Sci; 2016 Apr; 363():107-13. PubMed ID: 27000232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis.
    Benešová Y; Vašků A; Bienertová-Vašků J
    Acta Neurol Belg; 2018 Sep; 118(3):493-501. PubMed ID: 30069682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between CD24-P226-C/T polymorphism and multiple sclerosis: a meta-analysis.
    Jiang L; Bai X; Wang Y; Wei M
    Immunol Invest; 2015; 44(4):321-30. PubMed ID: 25942344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.
    Simsek H; Geckin H; Sensoz NP; List EO; Arman A
    J Mol Neurosci; 2019 Jan; 67(1):38-47. PubMed ID: 30443838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility to multiple sclerosis: the role of interleukin genes.
    Marrosu MG
    Lancet Neurol; 2007 Oct; 6(10):846-7. PubMed ID: 17884670
    [No Abstract]   [Full Text] [Related]  

  • 28. [Association analysis of cytokine receptors' genes polymorphisms with clinical features of multiple sclerosis].
    Kulakova OG; Bashinskaya VV; Tsareva EY; Boyko AN; Favorova OO; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10. Vyp. 2):10-15. PubMed ID: 28139605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association Between Genetic Polymorphism rs703842 in CYP27B1 and Multiple Sclerosis: A Meta-Analysis.
    Jiang T; Li L; Wang Y; Zhao C; Yang J; Ma D; Guan Y; Zhao D; Bao Y; Wang Y; Yang J
    Medicine (Baltimore); 2016 May; 95(19):e3612. PubMed ID: 27175669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication study of GWAS risk loci in Greek multiple sclerosis patients.
    Hadjigeorgiou GM; Kountra PM; Koutsis G; Tsimourtou V; Siokas V; Dardioti M; Rikos D; Marogianni C; Aloizou AM; Karadima G; Ralli S; Grigoriadis N; Bogdanos D; Panas M; Dardiotis E
    Neurol Sci; 2019 Feb; 40(2):253-260. PubMed ID: 30361804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
    Matesanz F; González-Pérez A; Lucas M; Sanna S; Gayán J; Urcelay E; Zara I; Pitzalis M; Cavanillas ML; Arroyo R; Zoledziewska M; Marrosu M; Fernández O; Leyva L; Alcina A; Fedetz M; Moreno-Rey C; Velasco J; Real LM; Ruiz-Peña JL; Cucca F; Ruiz A; Izquierdo G
    PLoS One; 2012; 7(5):e36140. PubMed ID: 22570697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis.
    Alcina A; Vandenbroeck K; Otaegui D; Saiz A; Gonzalez JR; Fernandez O; Cavanillas ML; Cénit MC; Arroyo R; Alloza I; García-Barcina M; Antigüedad A; Leyva L; Izquierdo G; Lucas M; Fedetz M; Pinto-Medel MJ; Olascoaga J; Blanco Y; Comabella M; Montalban X; Urcelay E; Matesanz F
    Genes Immun; 2010 Jul; 11(5):439-45. PubMed ID: 20508602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacogenomics of multiple sclerosis: association of immune response genes polymorphism with copaxone treatment efficacy].
    Tsareva EIu; Kulakova OG; Makarycheva OIu; Boĭko AN; Shchur SG; Lashch NIu; Popova NF; Gusev EI; Bashinskaia VV; L'vov DV; Favorov AV; Ochs MF; Favorova OO
    Mol Biol (Mosk); 2011; 45(6):963-72. PubMed ID: 22295566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenetics of multiple sclerosis.
    Svejgaard A
    Immunogenetics; 2008 Jun; 60(6):275-86. PubMed ID: 18461312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies.
    Zhang YJ; Zhang L; Chen SY; Yang GJ; Huang XL; Duan Y; Yang LJ; Ye DQ; Wang J
    Neurol Sci; 2018 Feb; 39(2):225-234. PubMed ID: 29110148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic variants regulate NR1H3 expression and contribute to multiple sclerosis risk.
    Zhang Y; Wang L; Jia H; Liao M; Chen X; Xu J; Bao Y; Liu G
    J Neurol Sci; 2018 Jul; 390():162-165. PubMed ID: 29801879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
    Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
    J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide significant association with seven novel multiple sclerosis risk loci.
    Lill CM; Luessi F; Alcina A; Sokolova EA; Ugidos N; de la Hera B; Guillot-Noël L; Malhotra S; Reinthaler E; Schjeide BM; Mescheriakova JY; Mashychev A; Wohlers I; Akkad DA; Aktas O; Alloza I; Antigüedad A; Arroyo R; Astobiza I; Blaschke P; Boyko AN; Buttmann M; Chan A; Dörner T; Epplen JT; Favorova OO; Fedetz M; Fernández O; García-Martínez A; Gerdes LA; Graetz C; Hartung HP; Hoffjan S; Izquierdo G; Korobko DS; Kroner A; Kubisch C; Kümpfel T; Leyva L; Lohse P; Malkova NA; Montalban X; Popova EV; Rieckmann P; Rozhdestvenskii AS; Schmied C; Smagina IV; Tsareva EY; Winkelmann A; Zettl UK; Binder H; Cournu-Rebeix I; Hintzen R; Zimprich A; Comabella M; Fontaine B; Urcelay E; Vandenbroeck K; Filipenko M; Matesanz F; Zipp F; Bertram L
    J Med Genet; 2015 Dec; 52(12):848-55. PubMed ID: 26475045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-7 receptor α-chain haplotypes differentially affect soluble IL-7 receptor and IL-7 serum concentrations in children with type 1 diabetes.
    Seyfarth J; Lundtoft C; Förtsch K; Ahlert H; Rosenbauer J; Baechle C; Roden M; Holl RW; Mayatepek E; Kummer S; Meissner T; Jacobsen M
    Pediatr Diabetes; 2018 Aug; 19(5):955-962. PubMed ID: 29484785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci.
    Kulakova O; Bashinskaya V; Kiselev I; Baulina N; Tsareva E; Nikolaev R; Kozin M; Shchur S; Favorov A; Boyko A; Favorova O
    Pharmacogenomics; 2017 Nov; 18(17):1563-1574. PubMed ID: 29095108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.